These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 28947337)

  • 41. Identification and characterization of stoichiometric and nonstoichiometric hydrate forms of paroxetine HCl: reversible changes in crystal dimensions as a function of water absorption.
    Pina MF; Pinto JF; Sousa JJ; Fábián L; Zhao M; Craig DQ
    Mol Pharm; 2012 Dec; 9(12):3515-25. PubMed ID: 23051151
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multicomponent Crystal of Mefenamic Acid and N-Methyl-d-Glucamine: Crystal Structures and Dissolution Study.
    Zaini E; Fitriani L; Sari RY; Rosaini H; Horikawa A; Uekusa H
    J Pharm Sci; 2019 Jul; 108(7):2341-2348. PubMed ID: 30779887
    [TBL] [Abstract][Full Text] [Related]  

  • 43. X-ray structural characterization of anhydrous metronidazole benzoate and metronidazole benzoate monohydrate.
    Caira MR; Nassimbeni LR; van Oudtshoorn B
    J Pharm Sci; 1993 Oct; 82(10):1006-9. PubMed ID: 8254484
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural relationships, thermal properties, and physicochemical characterization of anhydrous and solvated crystalline forms of tetroxoprim.
    Caira MR; Bettinetti G; Sorrenti M
    J Pharm Sci; 2002 Feb; 91(2):467-81. PubMed ID: 11835206
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of polymorphic ampicillin forms.
    Baraldi C; Tinti A; Ottani S; Gamberini MC
    J Pharm Biomed Anal; 2014 Nov; 100():329-340. PubMed ID: 25194347
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Solid state characterization of mometasone furoate anhydrous and monohydrate forms.
    Chen XS; Carillo M; Curtis Haltiwanger R; Bradley P
    J Pharm Sci; 2005 Nov; 94(11):2496-509. PubMed ID: 16200563
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Crystal doping aided by rapid expansion of supercritical solutions.
    Vemavarapu C; Mollan MJ; Needham TE
    AAPS PharmSciTech; 2002; 3(4):E29. PubMed ID: 12916923
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vapor-induced phase transformations in docetaxel.
    Tatini LK; Krishna Reddy KV; Someswara Rao N
    AAPS PharmSciTech; 2012 Jun; 13(2):548-55. PubMed ID: 22476972
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis, structural characterization, and biological studies of new antimony(III) complexes with thiones. The influence of the solvent on the geometry of the complexes.
    Ozturk II; Hadjikakou SK; Hadjiliadis N; Kourkoumelis N; Kubicki M; Baril M; Butler IS; Balzarini J
    Inorg Chem; 2007 Oct; 46(21):8652-61. PubMed ID: 17850141
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tasimelteon: a melatonin receptor agonist for non-24-hour sleep-wake disorder.
    Johnsa JD; Neville MW
    Ann Pharmacother; 2014 Dec; 48(12):1636-41. PubMed ID: 25204464
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Solid-State Study of the Structure, Dynamics, and Thermal Processes of Safinamide Mesylate─A New Generation Drug for the Treatment of Neurodegenerative Diseases.
    Pawlak T; Oszajca M; Szczesio M; Potrzebowski MJ
    Mol Pharm; 2022 Jan; 19(1):287-302. PubMed ID: 34856803
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polymorphism of linezolid: a combined single-crystal, powder diffraction and NMR study.
    Maccaroni E; Alberti E; Malpezzi L; Masciocchi N; Vladiskovic C
    Int J Pharm; 2008 Mar; 351(1-2):144-51. PubMed ID: 17977677
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tasimelteon for non-24-hour sleep-wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials.
    Lockley SW; Dressman MA; Licamele L; Xiao C; Fisher DM; Flynn-Evans EE; Hull JT; Torres R; Lavedan C; Polymeropoulos MH
    Lancet; 2015 Oct; 386(10005):1754-64. PubMed ID: 26466871
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.
    Rajaratnam SM; Polymeropoulos MH; Fisher DM; Roth T; Scott C; Birznieks G; Klerman EB
    Lancet; 2009 Feb; 373(9662):482-91. PubMed ID: 19054552
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preformulation evaluation of AZD1305, an oxabispidine intended for oral and intravenous treatment.
    Sigfridsson K; Lundqvist R; Ohlson K
    Drug Dev Ind Pharm; 2012 Jan; 38(1):19-31. PubMed ID: 21707325
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structure of lithium benzilate hemihydrate solved by simulated annealing and difference Fourier synthesis from powder data.
    Mora AJ; Fitch AN; Ramirez BM; Delgado GE; Brunelli M; Wright J
    Acta Crystallogr B; 2003 Jun; 59(Pt 3):378-83. PubMed ID: 12761407
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of the dual melatonin receptor agonist tasimelteon in subjects with hepatic or renal impairment.
    Torres R; Kramer WG; Baroldi P
    J Clin Pharmacol; 2015 May; 55(5):525-33. PubMed ID: 25450415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thermal, X-ray Structural, and Dissolution Characteristics of Solid Forms Derived from the Anticancer Agents 2-Methoxyestradiol and 2-Methoxyestradiol-3,17-O,O-Bis-Sulfamate.
    Caira MR; Bourne SA; Samsodien H
    J Pharm Sci; 2015 Oct; 104(10):3418-25. PubMed ID: 26073557
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Physicochemical and crystal structure analysis of pranlukast pseudo-polymorphs I: anhydrates and hydrate.
    Furuta H; Mori S; Yoshihashi Y; Yonemochi E; Uekusa H; Sugano K; Terada K
    J Pharm Biomed Anal; 2015 Mar; 107():11-6. PubMed ID: 25562844
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structural study of polymorphs and solvates of finasteride.
    Othman A; Evans JS; Evans IR; Harris RK; Hodgkinson P
    J Pharm Sci; 2007 May; 96(5):1380-97. PubMed ID: 17455354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.